[1]
Hattori, Y. 2022. Response to Glucose Deficiency with Sodium-Glucose Cotransporter 2 Inhibitors makes a Positive Impact on Heart and Kidney. Cardiology and Cardiovascular Medicine. 6, 1 (Jan. 2022), 13–18.